Jae Han Park

Jae Han Park is an accomplished pharmaceutical professional with extensive experience in formulations and technology transfer. Currently serving as Sr. Director at Mallinckrodt Pharmaceuticals since June 2017, Jae Han Park oversees patent analysis, process development, and technology transfer for various drug products, focusing on modified-release formulations. Prior roles include Director and Research Manager at Covidien, where responsibilities encompassed the development of generic pharmaceutical products and mentorship of scientific teams. Jae Han Park's career also includes a postdoctoral fellowship at Pfizer and a leadership position at HAITAI Food Research Center, contributing to the discovery of bioactive substances. Jae Han Park earned a Ph.D. in Pharmaceuticals from the University of Wisconsin-Madison.